邦睿生技股份有限公司 Approved
最後更新時間 2025/07/03 , 07:22 AM
最後更新時間 2025/07/03 , 07:22 AM
負責人
Xu,Zhen-Teng
統一編號
42686138
成立日期
2016/01/12
資本額
NT$500,000,000
實收資本額
NT$215,659,000
股票代號
6955
電話
04-24910985
地址
4F, No. 118, Gongye 9th Rd., Dali Dist., Taichung City, 412, Taiwan
董監事
姓名 職稱 持有股份 代表法人
Xu,Zhen-Teng Chairman 4.72%
Cai,Xiu-Juan Director 15.92% BO BANG CAPITAL CO., LTD.
Huang,Chun-Mu Director 4.57% BAI JUE INVESTMENT LTD.
Cai,Yu-Geng Director 12.91% Vivo Panda Fund, L.P.
Zheng,Sheng-Quan Director 0.80%
Wang,Shao-Hua Independent Director 0.00%
Wang,Yu-Xiang Independent Director 0.00%
Chen,Jie-Xiao Independent Director 0.00%
Zhou,Tian-Tai Independent Director 0.00%
營業項目
  • Manufacture of Irradiation and Electromedical Equipment(276000)
  • Manufacture of Other Medical Instruments and Supplies(332900)
  • Wholesale of Other Machinery and Equipment(464915)
  • Leasing of Intellectual Property and Similar Products, Except Copyrighted Works(774012)
  • 公司歷程
  • Change Capital to 500,000,000
    2022/07/28
  • 員工人數
    下載完整報告查看完整數據
    財務報表
    項目 2025 2024 2023
    Operating income 71,027 222,878 159,641
    Operating cost 15,678 47,920 39,851
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 55,349 174,958 119,790
    Unrealized profit (loss) on sales of goods - - -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net 55,349 174,958 119,790
    Operating expenses 32,609 114,007 98,450
    Other gain (loss), net - - -
    Operating profit (loss) 22,740 60,951 21,340
    Non-operating income and expenses 2,077 7,440 4,410
    Net profit (loss) before tax 24,817 68,391 25,750
    Income tax expense (benefits) 723 26 25
    Net profit (loss) of ongoing business for the current period 24,094 68,365 25,725
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period 24,094 68,365 25,725
    Other comprehensive profit (loss), net 84 217 -68
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period 24,178 68,582 25,657
    Net profit (loss) attributable to owners of parent company 24,094 68,365 25,725
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests 0 0 0
    Comprehensive profit (loss) attributable to owners of parent company 24,178 68,582 25,657
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests 0 0 0
    Basic earnings per share (yuan) 1 3 1
    項目 2025 2024 2023
    Net cash inflow (outflow) from operating activities 4,637 80,135 26,895
    Net cash inflows (outflows) from investing activities -162,722 -11,448 3,702
    Net cash inflow (outflow) from financing activities -811 221,202 -3,031
    Effect of Exchange Rate Changes on Cash and Cash Equivalents 3,425 3,406 -110
    Increase (decrease) in cash and cash equivalents in the current period -155,471 293,295 27,456
    Beginning balance of cash and cash equivalents 410,169 116,874 89,418
    Ending balance of cash and cash equivalents 254,698 410,169 116,874
    項目 2025 2024 2023
    Current asset 580,205 577,498 271,974
    Non-current asset 59,353 45,298 45,289
    Total asset 639,558 622,796 317,263
    Current liability 70,272 44,493 28,592
    Non-current liability 6,108 6,954 10,214
    Total liability 76,380 51,447 38,806
    share capital 215,659 215,659 170,860
    Equity - secruity token - - -
    capital reserve 280,525 280,525 80,511
    retained earning 67,021 75,276 27,414
    Other equity -27 -111 -328
    Treasury stock - - -
    Total equity attributable to owners of parent company 563,178 571,349 278,457
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests - - -
    Total Equity 563,178 571,349 278,457
    Share capital awaiting retirement (unit: share) 0 0 0
    Issued shares of advance equity (unit: shares) 0 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 0 0 0
    Net asset value per share 26 26 16
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
  • 萊特兒
  • LENSHOOKE
  • C-KUP
  • 邦睿生技股份有限公司標章
  • bonraybio
  • 專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
    勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。